Immix Biopharma, Inc. SEC filings IMMX
Immix Biopharma, Inc. has 244 filings in SEC EDGAR's recent list, going back to Jul 20, 2021. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 5, 2026 | — |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 4, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Dec 11, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Sep 17, 2025 | Sep 17, 2025 |
| 4 | Insider transaction | Sep 17, 2025 | Sep 16, 2025 |
| 3 | Initial insider ownership | Sep 17, 2025 | Sep 8, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2025 | — |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Aug 26, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 18, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2024 | — |
| 4 | Insider transaction | Dec 12, 2023 | Dec 8, 2023 |
| 4/A | Filing | Nov 9, 2023 | Aug 14, 2023 |
| 4/A | Filing | Nov 9, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 11, 2023 |
| 4 | Insider transaction | Sep 15, 2023 | Sep 14, 2023 |
| 4 | Insider transaction | Sep 14, 2023 | Sep 12, 2023 |
| 4 | Insider transaction | Sep 12, 2023 | Sep 8, 2023 |
| 4 | Insider transaction | Sep 11, 2023 | Sep 7, 2023 |
| 4 | Insider transaction | Sep 8, 2023 | Sep 6, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 5, 2023 |
| 4 | Insider transaction | Sep 5, 2023 | Aug 31, 2023 |
| SC 13D | Ownership over 5% (active) | Aug 30, 2023 | — |
| 4 | Insider transaction | Aug 23, 2023 | Aug 22, 2023 |
| 3 | Initial insider ownership | Aug 23, 2023 | Aug 22, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Nov 15, 2022 | Nov 14, 2022 |
| 4 | Insider transaction | Nov 15, 2022 | Nov 14, 2022 |
| 4/A | Filing | Jul 22, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| 4 | Insider transaction | Jul 18, 2022 | Jul 14, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 2, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| 3 | Initial insider ownership | Jan 18, 2022 | Dec 15, 2021 |
| SC 13G | Ownership over 5% (passive) | Dec 28, 2021 | — |
| 4 | Insider transaction | Dec 20, 2021 | Dec 20, 2021 |
| 4 | Insider transaction | Dec 20, 2021 | Dec 20, 2021 |
| 4 | Insider transaction | Dec 20, 2021 | Dec 20, 2021 |
| 4 | Insider transaction | Dec 20, 2021 | Dec 20, 2021 |
| 4 | Insider transaction | Dec 20, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
| 3 | Initial insider ownership | Dec 15, 2021 | Dec 15, 2021 |
Showing 112 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMMX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1873835
- Former names
- Immix Biopharma, Inc. (until Oct 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.